Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors
尿激酶型纤溶酶原激活剂 (uPA) 对结节性硬化症复合物 2 (TSC2) 缺陷型肿瘤的进展至关重要
期刊:Journal of Biological Chemistry
影响因子:4
doi:10.1074/jbc.M117.799593
Victoria Stepanova, Konstantin V Dergilev, Kelci R Holman, Yelena V Parfyonova, Zoya I Tsokolaeva, Mimi Teter, Elena N Atochina-Vasserman, Alla Volgina, Sergei V Zaitsev, Shane P Lewis, Fedor G Zabozlaev, Kseniya Obraztsova, Vera P Krymskaya, Douglas B Cines
